We are live on
!
Find out more
BGA
Belmont Global Advisors Portfolio holdings
AUM
$106M
1-Year Est. Return
2.89%
This Fund
S&P 500
This Quarter
Est. Return
+10.9%
1 Year Est. Return
-2.89%
3 Year Est. Return
+81.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$124M
AUM Growth
–
Cap. Flow
+$117M
Cap. Flow
% of AUM
94.29%
Top 10 Holdings %
Top 10 Hldgs %
37.9%
Holding
127
New
127
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alaunos Therapeutics
TCRT
|
+$10.2M |
| 2 |
RNET
RigNet, Inc.
RNET
|
+$6.16M |
| 3 |
Halozyme
HALO
|
+$4.4M |
| 4 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$4.27M |
| 5 |
Enterprise Products Partners
EPD
|
+$4.14M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 39.31% |
| 2 | Healthcare | 22.65% |
| 3 | Technology | 6.98% |
| 4 | Communication Services | 4.54% |
| 5 | Industrials | 4.47% |
Similar funds
LOT
EC
SAMNY
DCMM
PCM
SVGI
EDRM
EDRAML
Belmont Global Advisors's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Belmont Global Advisors, which disclosed 127 positions worth $124M. Its ten largest holdings account for 38% of the portfolio.
Its largest position is Alaunos Therapeutics: 17,100 shares worth $11.1M.
By sector, the portfolio is most concentrated in Energy at 39% of assets, followed by Healthcare and Technology.
- Belmont Global Advisors's largest Q4 2013 buy was Alaunos Therapeutics: 17,100 shares worth $11.1M.
- Belmont Global Advisors's ten largest holdings make up 38% of its $124M portfolio in Q4 2013.
- Belmont Global Advisors disclosed 127 positions in Q4 2013, its first 13F filing on record.
Based on Belmont Global Advisors's 13F filing for Q4 2013, filed 31 Jan 2014.